Gsa Capital Partners LLP Corcept Therapeutics Inc Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$22.21 - $34.48 $19,766 - $30,687	890 Added 2.94%	31,205 $1.01 Million
Q1 2024 May 03, 2024	SELL	$21.1 - $27.46 $229,884 - $299,176	-10,895 Reduced 26.44%	30,315 $763,000
Q4 2023 Feb 16, 2024	SELL	$24.82 - $32.88 $493,396 - $653,621	-19,879 Reduced 32.54%	41,210 $1.34 Million
Q3 2023 Nov 15, 2023	SELL	$21.97 - $33.8 $711,190 - $1.09 Million	-32,371 Reduced 34.64%	61,089 $1.66 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $16,530 - $19,390	771 Added 0.83%	93,460 $2.08 Million
Q1 2023 May 12, 2023	SELL	$19.2 - $24.47 $605,510 - $771,710	-31,537 Reduced 25.39%	92,689 $2.01 Million
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $1.96 Million - $2.94 Million	98,020 Added 374.04%	124,226 $2.52 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $284,099 - $334,938	11,502 Added 78.22%	26,206 $672,000
Q2 2022 Aug 09, 2022	BUY	$17.33 - $25.3 $50,101 - $73,142	2,891 Added 24.47%	14,704 $350,000
Q1 2022 May 11, 2022	BUY	$16.53 - $25.21 $195,268 - $297,805	11,813 New	11,813 $266,000
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $361,733 - $493,734	-21,154 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$19.68 - $22.53 $416,310 - $476,599	21,154 New	21,154 $416,000
Q1 2020 May 12, 2020	SELL	$10.11 - $14.04 $316,614 - $439,690	-31,317 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$12.06 - $16.96 $88,375 - $124,282	7,328 Added 30.55%	31,317 $379,000
Q3 2019 Nov 12, 2019	BUY	$10.41 - $14.66 $249,725 - $351,678	23,989 New	23,989 $339,000
Q2 2019 Aug 06, 2019	SELL	$9.78 - $12.76 $429,860 - $560,840	-43,953 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $132,375 - $207,340	-13,198 Reduced 23.09%	43,953 $516,000
Q4 2018 Feb 12, 2019	BUY	$11.29 - $17.19 $383,306 - $583,617	33,951 Added 146.34%	57,151 $764,000
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $1.06 Million - $1.35 Million	-86,182 Reduced 78.79%	23,200 $325,000
Q2 2018 Aug 09, 2018	SELL	$15.3 - $19.69 $1.27 Million - $1.63 Million	-82,800 Reduced 43.08%	109,382 $1.72 Million
Q1 2018 May 11, 2018	BUY	$14.59 - $25.5 $1.54 Million - $2.69 Million	105,600 Added 121.97%	192,182 $3.16 Million
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $1.02 Million - $1.34 Million	-64,700 Reduced 42.77%	86,582 $1.56 Million
Q3 2017 Nov 20, 2017	BUY	$12.3 - $19.3 $1.86 Million - $2.92 Million	151,282	151,282 $2.92 Million

Others Institutions Holding CORT

# of Institutions

349

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

Black Rock Inc. New York, NY

16.5M
Shares

$976 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$591 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.27M
Shares

$488 Million
14.93% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.51M
Shares

$384 Million
0.48% of portfolio
Parallel Advisors, LLC

3.81M
Shares

$225 Million
4.22% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.32B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account